đź“‹ FDA Reference
model 1551 switch control interface unit
Invacare
Summary: The Model 1551 Switch Control Interface Unit by Invacare is a medical device used primarily in tumor ablation procedures. It is utilized by clinicians in oncology and surgical settings to control ablation devices.
FDA Clearance Information
Pathway
510K
Number
K880360 ↗
Decision Date
September 19, 1988
Product Code
ITI
Device Class
Class 2
Evidence
0 studies
The Model 1551 was cleared through the FDA 510k pathway on September 19, 1988. Manufactured by Invacare, it is classified as a Class 2 medical device under product code ITI.
What It Is
The Model 1551 Switch Control Interface Unit is a device designed to facilitate the operation of tumor ablation systems. It acts as an intermediary control unit that allows precise manipulation of ablation parameters, ensuring accurate targeting and energy delivery. This device is crucial in procedures where precise control over the ablation process is necessary to maximize therapeutic outcomes while minimizing damage to surrounding tissues.
Clinical Applications
Commonly used in oncology and surgical settings, the Model 1551 is integral to procedures involving tumor ablation, particularly in cases where non-invasive or minimally invasive techniques are preferred. It is suitable for use in hospitals and specialized cancer treatment centers, often by oncologists and surgical teams. The device is applicable to a wide range of patient populations, especially those with solid tumors requiring precise ablation.
Indications for Use
The FDA indications suggest that the Model 1551 is intended for use in tumor ablation, a procedure that destroys cancerous tissues using heat, cold, or chemical agents. It is particularly useful for patients with localized tumors where surgical resection is not feasible.
Practical Considerations
The Model 1551 is typically compatible with a variety of ablation systems, offering flexibility in clinical settings. Clinicians should ensure compatibility with existing equipment and be familiar with the interface to optimize its use. Proper training on the device's operation is essential to ensure safety and efficacy during procedures.
Related Literature
The linked study explores the self-assembly of peptides using a novel 2D funnel structure, which may have implications for biochip design and biomedical applications. Although not directly related to the Model 1551, the study highlights the importance of precise control in biomedical devices. Limitations include its focus on theoretical models rather than clinical applications.
Frequently Asked Questions
What is the Model 1551 Switch Control Interface Unit used for?
It is used to control tumor ablation devices, allowing precise manipulation of ablation parameters during oncology procedures.
What specialties typically use this device?
Oncologists and surgical teams in oncology and surgical settings commonly use this device.
What are the FDA-cleared indications?
The device is indicated for use in tumor ablation procedures, particularly for patients with localized tumors.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.